The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities.
作者信息
Chandler Rebecca E
机构信息
International Society of Pharmacovigilance, London, UK.
出版信息
Drug Saf. 2022 Jun;45(6):597-599. doi: 10.1007/s40264-022-01179-y. Epub 2022 May 9.
Abstract
摘要
相似文献
1
The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities.国际药物警戒协会疫苗特别兴趣小组：挑战与机遇
Drug Saf. 2022 Jun;45(6):597-599. doi: 10.1007/s40264-022-01179-y. Epub 2022 May 9.
2
Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety.国际药物警戒学会用药错误特别兴趣小组与患者安全国际合作趋势
Drug Saf. 2022 Feb;45(2):97-99. doi: 10.1007/s40264-021-01145-0. Epub 2022 Jan 17.
3
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.促进安全用药沟通：国际药物警戒学会特别兴趣小组推动的2020年代进展与方向
Drug Saf. 2023 Jun;46(6):517-532. doi: 10.1007/s40264-023-01285-5. Epub 2023 May 23.
4
Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events.使疫苗监测系统现代化，以改善对罕见或定义不明确的不良事件的检测。
BMJ. 2019 May 31;365:l2268. doi: 10.1136/bmj.l2268.
5
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.国际药物警戒协会（ISoP）药物基因组学特别兴趣小组：药物警戒中的药物基因组学。
Drug Saf. 2021 Jun;44(6):615-617. doi: 10.1007/s40264-021-01068-w. Epub 2021 May 8.
6
Vaccine pharmacovigilance in India: Current context and future perspective.印度疫苗药物警戒：当前背景与未来展望。
Indian J Pharmacol. 2019 Jul-Aug;51(4):243-247. doi: 10.4103/ijp.IJP_53_19.
7
Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System.疫苗与心房颤动：一项基于疫苗不良事件报告系统的真实世界药物警戒研究
Am J Ther. 2023;30(2):151-153. doi: 10.1097/MJT.0000000000001546. Epub 2022 Jul 19.
8
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.评估疫苗上市后安全性面临的挑战：来自疾病预防控制中心的观察。
Expert Rev Vaccines. 2019 Oct;18(10):1091-1101. doi: 10.1080/14760584.2019.1676154. Epub 2019 Oct 19.
9
Which pharmacovigilance for vaccines?哪种疫苗的药物警戒？
Bull Acad Natl Med. 2016 Feb;200(2):241-250.
10
Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.所有国家建立有效的疫苗安全体系：实现更公平获得免疫接种的挑战。
Vaccine. 2013 Apr 18;31 Suppl 2:B108-14. doi: 10.1016/j.vaccine.2012.10.119.
引用本文的文献
1
The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs).国际药物警戒科学合作组织（ISoP）在中低收入国家药物警戒发展中的作用
Drug Saf. 2023 Dec;46(12):1307-1312. doi: 10.1007/s40264-023-01363-8. Epub 2023 Oct 24.
本文引用的文献
1
Menstrual Symptoms After COVID-19 Vaccine: A Cross-Sectional Investigation in the MENA Region.新冠疫苗接种后的月经症状：中东和北非地区的横断面调查
Int J Womens Health. 2022 Mar 28;14:395-404. doi: 10.2147/IJWH.S352167. eCollection 2022.
2
Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey.新冠疫苗接种后月经不规律情况的评估：MECOVAC调查结果
Open Med (Wars). 2022 Mar 9;17(1):475-484. doi: 10.1515/med-2022-0452. eCollection 2022.
3
Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination: A U.S. Cohort.月经周期长度与 2019 冠状病毒病（COVID-19）疫苗接种的关联：一项美国队列研究。
Obstet Gynecol. 2022 Apr 1;139(4):481-489. doi: 10.1097/AOG.0000000000004695. Epub 2022 Jan 5.
4
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.以色列接种 BNT162b2 mRNA 疫苗后出现心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi: 10.1056/NEJMoa2109730. Epub 2021 Oct 6.
5
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
6
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
7
Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival.大流行流感疫苗（潘纳利克斯）诱发的嗜睡症与免疫和神经元存活相关的基因有关。
EBioMedicine. 2019 Feb;40:595-604. doi: 10.1016/j.ebiom.2019.01.041. Epub 2019 Jan 30.
8
Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age.登革热疫苗会使血清阴性人群易感染增强疾病，无论其年龄如何。
Vaccine. 2017 Nov 7;35(47):6355-6358. doi: 10.1016/j.vaccine.2017.09.089. Epub 2017 Oct 10.
9
Adversomics: a new paradigm for vaccine safety and design.药物不良反应组学：疫苗安全性与设计的新范式
Expert Rev Vaccines. 2015 Jul;14(7):935-47. doi: 10.1586/14760584.2015.1038249. Epub 2015 May 2.
Zotero 插件